Tumor-suppressive functions of leucine zipper transcription factor-like 1

Cancer Research

Volumn 70, Issue 7, 2010, Pages 2942-2950

  Wei, Qun ^a,b   Zhou, Wen ^b   Wang, Weining ^b   Gao, Boning ^b   Wang, Linbo ^a   Cao, Jiang ^a   Liu, Zhi Ping ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUCINE ZIPPER TRANSCRIPTION FACTOR LIKE 1 GENE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; TISSUE MICROARRAY;

ANIMALS; CADHERINS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL MEMBRANE; DOWN-REGULATION; DOXYCYCLINE; EPITHELIAL CELLS; HELA CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; PROGNOSIS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 77950794746     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3826     Document Type: Article

References (17)

1. Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 2005;1:79-92.
2. Hesson LB, Cooper WN, Latif F. Evaluation of the 3p21.3 tumorsuppressor gene cluster. Oncogene 2007;26:7283-7301
3. Kiss H, Kedra D, Kiss C, et al. The LZTFL1 gene is a part of a transcriptional map covering 250 kb within the common eliminated region 1 (C3CER1) in 3p21.3. Genomics 2001;73:10-19
4. Vinson C, Acharya A, Taparowsky EJ. Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta 2006;1759:4-12.
5. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009;28:151-166
6. Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does Cadherin dysfunction promote tumor progression? Oncogene 2008; 27:6920-6929
7. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428
8. Guan KL, Dixon JE. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem 1991; 192:262-267
9. Zhou YQ, He C, Chen YQ, Wang D, Wang MH. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing variants and their oncogenic potential. Oncogene 2003;22:186-197 (Pubitemid 36174176)
10. Momparler RL. Epigenetic therapy of cancer with 5-aza-2′- deoxycytidine (decitabine). Semin Oncol 2005;32:443-451 (Pubitemid 41396420)
11. Botrugno OA, Santoro F, Minucci S. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett 2009;280:134-144
12. Howell PM, Jr., Liu S, Ren S, Behlen C, Fodstad O, Riker Al. Epigenetics in human melanoma. Cancer Control 2009;16:200-218
13. Pfeifer GP, Rauch TA. DNA methylation patterns in lung carcinomas. Semin Cancer Biol 2009;19:181-187
14. Cohen E, Ophir I, Shaul YB. Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci 1999;112: 2657-2666
15. Cummings TH, Pomare EW, Branch WJ, Naylor CPE, MacFarlane GT. Short chain fatty acids in human large intestine, portal, hepatic, and venous blood. Gut 1987;28:1221-1227
16. Pinto D, Clevers H. Wnt, stem cells and cancer in the intestine. Biol Cell 2005;97:185-196 (Pubitemid 40360891)
17. Diaz VM, Hurtado M, Kort EJ, et al. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells. Exp Cell Res 2006;312:2203-2213